Pune, India, July 12, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, global US Acne Treatment Market size was valued at USD 4.27 billion in 2021 and projected to grow from USD 4.50 billion in 2022 to USD 6.12 billion by 2029, exhibiting a CAGR of 4.5% during the forecast period. Strong adoption of cosmeceutical treatment procedures and rising acne cases may bolster market growth. Fortune Business Insights™ presents this information in its report titled “US Acne Treatment Market, 2022-2029.”
Industry Development
Zelira Therapeutics Ltd. announced its initial line of products, RAF FIVE, through the subsidiary brand Ilera Derm LLC.
Sun Pharmaceutical Industries Ltd. announced its partnership with Cassiopea SpA for exclusive distribution rights of Winlevi (clascoterone cream 1%) in the U.S. and Canada. The brand has approval for usage in the treatment of acne for patients of 12 years and above.
Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-acne-treatment-market-106565
Key Takeaways:
- Increasing adoption of cosmeceuticals as a supportive treatment are key factors anticipated to increase the demand for products.
- U.S. patient improving adoption rates for the acne treatment, thereby bolstering the U.S. acne treatment market growth.
- The market is segmented into retinoids, antibiotics, isotretinoin, and others rising demand for acne treatment during the forecast period.
Discover the Leading Players Featured in the Report:
“Companies leading the global US acne treatment market are Bausch Health Companies Inc. (Canada), GALDERMA (Switzerland), Pfizer Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), GlaxoSmithKline Plc. (U.K.), Allergan (Ireland), Mayne Pharma Group Limited (Australia), Sun Pharmaceutical Industries Ltd. (India), Reckitt Benckiser Group PLC. (U.K.), Padagis (U.S.), Almirall, S.A (Spain)”
Report Scope & Segmentation
| Report Coverage | Details |
| Forecast Period | 2022 to 2029 |
| Forecast Period 2022 to 2029 CAGR | 4.5% |
| 2029 Value Projection | USD 6.12 Billion |
| Base Year | 2021 |
| Market Size in 2022 | USD 4.50 Billion |
| Historical Data | 2018 to 2020 |
| No. of Pages | 97 |
| Segments covered | By Product Type, Treatment Modality, Age Group, and Distribution Channel |
Acne treatment is a procedure that eliminates oil, dirt, dead skin cells, sebum, and hair follicles. Strong adoption of cosmeceuticals in skin treatment procedures and the rise in acne cases are expected to propel service adoption. Furthermore, the rising diagnosis of acne disorders among the population is expected to boost the adoption of treatment procedures. For example, as per the American Academy of Dermatology Association’s information, acne disorder is commonly diagnosed in the U.S., affecting nearly 50 million Americans annually. These factors may boost the U.S. acne treatment market share in the coming years.
Browse Complete Report Details: https://www.fortunebusinessinsights.com/u-s-acne-treatment-market-106565
Drivers and Restraints
Launch of Novel Acne Products to Propel Market Development
The rising prevalence of acne procedures is expected to propel the adoption of the product from the region. The rising demand for effective medical procedures may increase acne treatment procedures. For example, as per the information provided by the American Academy of Dermatology, acne vulgaris is the most commonly diagnosed disorder in the U.S. and affects more than 50 million individuals, including 85% adults and teenagers. Furthermore, the rising government initiatives are expected to drive the U.S. acne treatment market growth.
However, the side effects of acne treatment products are expected to hinder the market’s progress.
Competitive Landscape
Major Players Implement Partnerships to Boost Brand Image
The prominent companies operating in the market implement partnerships to boost their brand image. For example, Sun Pharmaceutical Industries Ltd. partnered with Cassiopea SpA to obtain exclusive distribution rights of Winlevi (clascoterone cream 1%) in Canada and the U.S. in August 2021. This development may enable the company to boost its brand image. Furthermore, the adoption of novel products, mergers, acquisitions, and expansions is expected to boost its market position.
Quick Buy - US Acne Treatment Market Research Report: https://www.fortunebusinessinsights.com/compare-plan/106565
Market Segmentation:
By product type, the market is segmented into isotretinoin, antibiotics, retinoids, and others. Based on treatment mobility, it is bifurcated into tropical and oral. By age, it is classified into 10 to 17, 18 to 44, 45 to 64, and 65 and above. As per distribution channel, it is clubbed into hospital pharmacies and retail pharmacies.
By Product Type
- Retinoids
- Antibiotics
- Isotretinoin
- Others
By Treatment Modality
- Oral
- Topical
By Age Group
- 10 to 17
- 18 to 44
- 45 to 64
- 65 and Above
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-acne-treatment-market-106565
FAQ’s
How big is the acne treatment market in the US?
The US acne treatment market size was USD 4.50 billion in 2022. It is expected to reach USD 6.12 billion by 2029.
How fast is the US acne treatment market growing?
The US acne treatment market will exhibit a CAGR of 4.5% during the forecast period, 2022-2029.
Related Reports:
U.S. Dermal Fillers Market Size, Share, Revenue Forecast and Opportunities
U.S. Retail Clinics Market Size, Industry Share, Revenue and Forecast
U.S. Pharmacy Market Size, Share, Opportunities & Analysis
Cosmetic Surgery Market Growth, Industry Analysis, Demand and Forecast
Cosmeceuticals Market Size, Share, Opportunities & Analysis
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.: +1 424 253 0390
U.K.: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
